Emerald Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $633K | Buy |
1,941
+445
| +30% | +$145K | 0.02% | 167 |
|
|
2025
Q1 | $404K | Sell |
1,496
-84
| -5% | -$22.7K | 0.02% | 176 |
|
|
2024
Q4 | $372K | Buy |
1,580
+3
| +0.2% | +$706 | 0.01% | 194 |
|
|
2024
Q3 | $434K | Sell |
1,577
-41
| -3% | -$11.3K | 0.02% | 186 |
|
|
2024
Q2 | $393K | Sell |
1,618
-452
| -22% | -$110K | 0.02% | 183 |
|
|
2024
Q1 | $309K | Sell |
2,070
-24
| -1% | -$3.59K | 0.01% | 202 |
|
|
2023
Q4 | $401K | Sell |
2,094
-925
| -31% | -$177K | 0.02% | 191 |
|
|
2023
Q3 | $535K | Sell |
3,019
-67
| -2% | -$11.9K | 0.03% | 168 |
|
|
2023
Q2 | $586K | Sell |
3,086
-46
| -1% | -$8.74K | 0.03% | 167 |
|
|
2023
Q1 | $627K | Buy |
3,132
+575
| +22% | +$115K | 0.03% | 166 |
|
|
2022
Q4 | $608K | Sell |
2,557
-43
| -2% | -$10.2K | 0.03% | 156 |
|
|
2022
Q3 | $520K | Sell |
2,600
-21
| -0.8% | -$4.2K | 0.03% | 167 |
|
|
2022
Q2 | $382K | Sell |
2,621
-315
| -11% | -$45.9K | 0.02% | 188 |
|
|
2022
Q1 | $479K | Sell |
2,936
-54
| -2% | -$8.81K | 0.02% | 192 |
|
|
2021
Q4 | $507K | Sell |
2,990
-42
| -1% | -$7.12K | 0.02% | 189 |
|
|
2021
Q3 | $572K | Sell |
3,032
-1,057
| -26% | -$199K | 0.02% | 183 |
|
|
2021
Q2 | $693K | Hold |
4,089
| – | – | 0.03% | 178 |
|
|
2021
Q1 | $577K | Sell |
4,089
-180
| -4% | -$25.4K | 0.02% | 184 |
|
|
2020
Q4 | $555K | Sell |
4,269
-3,370
| -44% | -$438K | 0.02% | 191 |
|
|
2020
Q3 | $1.11M | Sell |
7,639
-90
| -1% | -$13.1K | 0.05% | 142 |
|
|
2020
Q2 | $1.15M | Sell |
7,729
-1,445
| -16% | -$214K | 0.05% | 140 |
|
|
2020
Q1 | $999K | Sell |
9,174
-111
| -1% | -$12.1K | 0.06% | 137 |
|
|
2019
Q4 | $1.07M | Sell |
9,285
-1,385
| -13% | -$159K | 0.05% | 143 |
|
|
2019
Q3 | $858K | Sell |
10,670
-1,494
| -12% | -$120K | 0.04% | 148 |
|
|
2019
Q2 | $883K | Sell |
12,164
-1,094
| -8% | -$79.4K | 0.04% | 156 |
|
|
2019
Q1 | $1.24M | Buy |
13,258
+73
| +0.6% | +$6.82K | 0.05% | 157 |
|
|
2018
Q4 | $961K | Sell |
13,185
-5,033
| -28% | -$367K | 0.05% | 154 |
|
|
2018
Q3 | $1.59M | Buy |
18,218
+483
| +3% | +$42.3K | 0.06% | 147 |
|
|
2018
Q2 | $1.75M | Buy |
17,735
+3,868
| +28% | +$381K | 0.07% | 139 |
|
|
2018
Q1 | $1.65M | Sell |
13,867
-996
| -7% | -$119K | 0.07% | 151 |
|
|
2017
Q4 | $1.89M | Sell |
14,863
-930
| -6% | -$118K | 0.07% | 133 |
|
|
2017
Q3 | $1.86M | Sell |
15,793
-1,529
| -9% | -$180K | 0.08% | 143 |
|
|
2017
Q2 | $1.38M | Sell |
17,322
-19,831
| -53% | -$1.58M | 0.06% | 156 |
|
|
2017
Q1 | $1.9M | Sell |
37,153
-31
| -0.1% | -$1.59K | 0.08% | 157 |
|
|
2016
Q4 | $1.39M | Sell |
37,184
-5,763
| -13% | -$216K | 0.06% | 171 |
|
|
2016
Q3 | $2.91M | Buy |
42,947
+2,908
| +7% | +$197K | 0.13% | 180 |
|
|
2016
Q2 | $2.22M | Buy |
40,039
+14,545
| +57% | +$807K | 0.11% | 197 |
|
|
2016
Q1 | $1.6M | Buy |
25,494
+2,559
| +11% | +$161K | 0.08% | 213 |
|
|
2015
Q4 | $2.16M | Sell |
22,935
-7,548
| -25% | -$711K | 0.1% | 201 |
|
|
2015
Q3 | $2.45M | Sell |
30,483
-12,602
| -29% | -$1.01M | 0.13% | 185 |
|
|
2015
Q2 | $5.17M | Sell |
43,085
-8,638
| -17% | -$1.04M | 0.25% | 125 |
|
|
2015
Q1 | $5.42M | Sell |
51,723
-199,009
| -79% | -$20.8M | 0.27% | 121 |
|
|
2014
Q4 | $24.3M | Sell |
250,732
-51,211
| -17% | -$4.97M | 1.29% | 11 |
|
|
2014
Q3 | $23.6M | Sell |
301,943
-8,927
| -3% | -$697K | 1.4% | 6 |
|
|
2014
Q2 | $19.6M | Buy |
310,870
+14,132
| +5% | +$893K | 1.11% | 11 |
|
|
2014
Q1 | $19.9M | Sell |
296,738
-14,728
| -5% | -$989K | 1.12% | 13 |
|
|
2013
Q4 | $20M | Sell |
311,466
-71,588
| -19% | -$4.6M | 1.08% | 18 |
|
|
2013
Q3 | $24.5M | Sell |
383,054
-6,787
| -2% | -$434K | 1.38% | 8 |
|
|
2013
Q2 | $12.1M | Buy |
+389,841
| New | +$12.1M | 0.74% | 40 |
|